CLS Holdings USA Inc (CLSH)
0.05
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
CLS Holdings USA Enterprise Value: 12.09M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 31, 2024 | 12.09M |
May 30, 2024 | 11.91M |
May 29, 2024 | 13.02M |
May 28, 2024 | 13.19M |
May 24, 2024 | 11.52M |
May 23, 2024 | 12.36M |
May 22, 2024 | 12.36M |
May 21, 2024 | 12.64M |
May 20, 2024 | 12.64M |
May 17, 2024 | 12.64M |
May 16, 2024 | 12.64M |
May 15, 2024 | 12.64M |
May 14, 2024 | 12.77M |
May 13, 2024 | 12.46M |
May 10, 2024 | 12.93M |
May 09, 2024 | 12.77M |
May 08, 2024 | 12.77M |
May 07, 2024 | 12.45M |
May 06, 2024 | 12.09M |
May 03, 2024 | 12.09M |
May 02, 2024 | 12.77M |
May 01, 2024 | 12.77M |
April 30, 2024 | 12.77M |
April 29, 2024 | 12.43M |
April 26, 2024 | 12.64M |
Date | Value |
---|---|
April 25, 2024 | 12.77M |
April 24, 2024 | 12.77M |
April 23, 2024 | 12.77M |
April 22, 2024 | 12.77M |
April 19, 2024 | 12.77M |
April 18, 2024 | 12.77M |
April 17, 2024 | 12.77M |
April 16, 2024 | 12.77M |
April 15, 2024 | 12.77M |
April 12, 2024 | 12.07M |
April 11, 2024 | 12.14M |
April 10, 2024 | 12.35M |
April 09, 2024 | 12.60M |
April 08, 2024 | 13.17M |
April 05, 2024 | 12.15M |
April 04, 2024 | 12.64M |
April 03, 2024 | 12.64M |
April 02, 2024 | 12.64M |
April 01, 2024 | 12.04M |
March 28, 2024 | 12.04M |
March 27, 2024 | 12.04M |
March 26, 2024 | 12.04M |
March 25, 2024 | 12.04M |
March 22, 2024 | 12.09M |
March 21, 2024 | 12.09M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
11.35M
Minimum
Nov 15 2023
60.15M
Maximum
Feb 10 2021
27.66M
Average
28.92M
Median
Feb 19 2020
Enterprise Value Benchmarks
NovaBay Pharmaceuticals Inc | 4.387M |
Palatin Technologies Inc | 19.03M |
iBio Inc | 28.91M |
Theriva Biologics Inc | -10.98M |
Oragenics Inc | 8.699M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -4.369M |
Revenue (Quarterly) | 4.926M |
Total Expenses (Quarterly) | 5.365M |
EPS Diluted (Quarterly) | -0.04 |
Gross Profit Margin (Quarterly) | 43.17% |
Profit Margin (Quarterly) | -88.69% |
Earnings Yield | -220.0% |
Normalized Earnings Yield | -137.01 |